Chrysalis Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 165.57%
- Profit Growth 81.19%
- Ebitda 93.43%
- Net Worth -3.37%
- Total Assets 539.64%
About Chrysalis Pharma
Chrysalis Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 June 2014 and has a history of Ten years and seven months. Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239HR2014PTC052499
-
Company No.
052499
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jun 2014
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Chrysalis Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Shahi
|
Director | 11-Jun-2014 | Current |
|
Riyaz Khan
|
Director | 11-Jun-2014 | Current |
Financial Performance of Chrysalis Pharma.
Chrysalis Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 165.57% increase. The company also saw a substantial improvement in profitability, with a 81.19% increase in profit. The company's net worth dipped by a decrease of 3.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chrysalis Pharma?
In 2020, Chrysalis Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Biomade Life Sciences LlpAnil Shahi and Riyaz Khan are mutual person
-
Pharmaplus Remedies Private Limited
Anil Shahi is a mutual person
-
Biomade Life Care Private Limited
Anil Shahi and Riyaz Khan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chrysalis Pharma?
Unlock and access historical data on people associated with Chrysalis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chrysalis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chrysalis Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
